Logo

Hyseq Expands Genomics Program, Names Director

Nov 14, 1998
Premium

SUNNYVALE, Calif.--Hyseq announced the appointment of Dennis Ballinger as senior director of functional genomics/cardiovascular. The company said it plans to strengthen its development program in the genetic causes of cardiovascular diseases. Ballinger joined Hyseq from Myriad Genetics, where he was director of coronary heart disease research.

Hyseq said it is leveraging its high-throughput proprietary sequencing technology to identify valuable gene-based therapeutic candidates. The company claimed it has processed more than 7.5 million sequences and filed patents on over 95,000 novel gene discoveries.

Filed under

Informatics
Breaking News
The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.